Appalachia Struggles With Opioids, Minnesota With Meth - Diverse Health

Higher Education News and Jobs

Appalachia Struggles With Opioids, Minnesota With Meth

Email
   
        


by Erin Mundahl

To say opioid addiction has spiked is an understatement. Over the course of the past few years, heroin addiction has grown from a limited problem primarily constrained to urban areas, to a nationwide scourge so large that drug overdose is now the leading cause of death for Americans under 50. The sheer scale of America’s current heroin and opioid epidemic is well documented, but just because opioid addiction is a public health and law enforcement problem across the country does not mean that the problem looks the same in all states. Minnesota shares in some national trends, but has certain problems that are all its own.

<div style=”text-decoration: underline;” align=”right”><a href=”http://www.insidesources.com/minnesota-battles-meth/” target=”_blank”>Read More</a></div>

Comments

Print Friendly

Related Articles

Repeal Would Hurt Students with Disabilities On the eastern end of Michigan’s Upper Peninsula, Rachel Fuerer’s school district depends on more than $870,000 in Medicaid funds each year. About 5 percent of its overall annual budget, the money goes toward providing medical services for more than ...
Uninsured, Rural, & Poor Line Up for Care in Tents WISE, Va. — Anthony Marino, 54, reached into his car trunk to show a pair of needle-nosed pliers like the ones he used to yank out a rotting tooth. Shirley Akers, 58, clutched a list of 20 medications she takes, before settling down to a sleepless...
Latinos Sue California Over Healthcare Gaps California is harming medical care for more than 13 million lower-income residents, more than half of them Latinos, by failing to pay doctors enough to provide proper care, according to a lawsuit filed Wednesday. The lawsuit alleges the state viol...
Research: Blood Tests Could Predict Alzheimer’s Researchers from Missouri reveal that blood test screening may identify markers of Alzheimer's disease before individuals begin to experience memory loss and confusion. This finding is a significant step toward predicting disease risk. Read More